This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nitsche, F. Articles by Rickinson, A. Search for Related Content PubMed PubMed Citation Articles by Nitsche, F. Articles by Rickinson, A.

 Previous Article  |  Next Article 

J. Virol., Sep 1997, 6619-6628, Vol 71, No. 9
Copyright © 1997, American Society for Microbiology

Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain

F Nitsche, A Bell and A Rickinson
CRC Institute for Cancer Studies, University of Birmingham, United Kingdom.

The Epstein-Barr virus (EBV)-encoded leader protein EBNA-LP is made up of several 66-amino-acid repeats (the W1W2 domains) linked to a unique 45-amino-acid C-terminal sequence (the Y1Y2 domain). This protein is highly expressed along with a second nuclear antigen, EBNA-2, during the initial stages of virus-induced B-cell transformation. While EBNA- 2's essential role in transformation as a transcriptional activatory is well documented, very little is known about EBNA-LP function except that recombinant viruses lacking the EBNA-LP Y1Y2 exons show reduced, but still detectable, transforming ability. This was taken as evidence that EBNA-LP plays an auxiliary role but is not essential for transformation. A recent study showed that EBNA-LP could cooperate with EBNA-2 in activating cyclin D2 transcription in resting B cells (A.J. Sinclair, L Palmero, G. Peters, and P.J. Farrell, EMBO J. 13:3321-3328, 1994). Here we report that EBNA-LP can also cooperate with EBNA-2 in up- regulating expression of the major EBV effector protein of B-cell transformation, latent membrane protein 1 (LMP1). In transient- transfection assays, EBNA-LP enhanced the level of EBNA-2-induced LMP1 expression by 5- to 10-fold in one Latency I Burkitt's lymphoma cell line, Eli-BL, and was absolutely required, along with EBNA-2, to induce LMP1 in a second line, Akata-BL. These changes in LMP1 protein expression appeared to be reflected at the transcriptional level. A study of EBNA-LP mutants showed that this cooperative function mapped to the W1W2 repeat domain rather than to Y1Y2. Because a Y1Y2-deleted form of EBNA-LP may therefore retain some aspects of wild-type function, the original data from virus recombinants leave open the possibility that EBNA-LP is actually an essential transforming gene.

This article has been cited by other articles:

• Ling, P. D., Tan, J., Sewatanon, J., Peng, R. (2008). Murine Gammaherpesvirus 68 Open Reading Frame 75c Tegument Protein Induces the Degradation of PML and Is Essential for Production of Infectious Virus. J. Virol. 82: 8000-8012 [Abstract] [Full Text]  
• Garibal, J., Hollville, E., Bell, A. I., Kelly, G. L., Renouf, B., Kawaguchi, Y., Rickinson, A. B., Wiels, J. (2007). Truncated Form of the Epstein-Barr Virus Protein EBNA-LP Protects against Caspase-Dependent Apoptosis by Inhibiting Protein Phosphatase 2A. J. Virol. 81: 7598-7607 [Abstract] [Full Text]  
• Peng, C.-W., Zhao, B., Chen, H.-C., Chou, M.-L., Lai, C.-Y., Lin, S.-Z., Hsu, H.-Y., Kieff, E. (2007). Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2. Blood 109: 5447-5454 [Abstract] [Full Text]  
• Law, A. H. Y., Lee, D. C. W., Cheung, B. K. W., Yim, H. C. H., Lau, A. S. Y. (2007). Role for Nonstructural Protein 1 of Severe Acute Respiratory Syndrome Coronavirus in Chemokine Dysregulation. J. Virol. 81: 416-422 [Abstract] [Full Text]  
• Jimenez-Ramirez, C., Brooks, A. J., Forshell, L. P., Yakimchuk, K., Zhao, B., Fulgham, T. Z., Sample, C. E. (2006). Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter. J. Virol. 80: 11200-11208 [Abstract] [Full Text]  
• Goormachtigh, G., Ouk, T.-S., Mougel, A., Tranchand-Bunel, D., Masy, E., Le Clorennec, C., Feuillard, J., Bornkamm, G. W., Auriault, C., Manet, E., Fafeur, V., Adriaenssens, E., Coll, J. (2006). Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-{kappa}B and JNK Signaling Pathways.. J. Virol. 80: 7382-7393 [Abstract] [Full Text]  
• Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Zhao, B., Kieff, E. (2005). Epstein-Barr Virus Nuclear Protein 3A Domains Essential for Growth of Lymphoblasts: Transcriptional Regulation through RBP-J{kappa}/CBF1 Is Critical. J. Virol. 79: 10171-10179 [Abstract] [Full Text]  
• Yue, W., Gershburg, E., Pagano, J. S. (2005). Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter. J. Virol. 79: 5880-5885 [Abstract] [Full Text]  
• Peng, R., Moses, S. C., Tan, J., Kremmer, E., Ling, P. D. (2005). The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter. J. Virol. 79: 4492-4505 [Abstract] [Full Text]  
• Chang, Y., Lee, H.-H., Chang, S.-S., Hsu, T.-Y., Wang, P.-W., Chang, Y.-S., Takada, K., Tsai, C.-H. (2004). Induction of Epstein-Barr Virus Latent Membrane Protein 1 by a Lytic Transactivator Rta. J. Virol. 78: 13028-13036 [Abstract] [Full Text]  
• Lee, J. M., Lee, K.-H., Farrell, C. J., Ling, P. D., Kempkes, B., Park, J. H., Hayward, S. D. (2004). EBNA2 Is Required for Protection of Latently Epstein-Barr Virus-Infected B Cells against Specific Apoptotic Stimuli. J. Virol. 78: 12694-12697 [Abstract] [Full Text]  
• Peng, C.-W., Zhao, B., Kieff, E. (2004). Four EBNA2 Domains Are Important for EBNALP Coactivation. J. Virol. 78: 11439-11442 [Abstract] [Full Text]  
• Sutkowski, N., Chen, G., Calderon, G., Huber, B. T. (2004). Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen. J. Virol. 78: 7852-7860 [Abstract] [Full Text]  
• Gordadze, A. V., Onunwor, C. W., Peng, R., Poston, D., Kremmer, E., Ling, P. D. (2004). EBNA2 Amino Acids 3 to 30 Are Required for Induction of LMP-1 and Immortalization Maintenance. J. Virol. 78: 3919-3929 [Abstract] [Full Text]  
• Kanamori, M., Watanabe, S., Honma, R., Kuroda, M., Imai, S., Takada, K., Yamamoto, N., Nishiyama, Y., Kawaguchi, Y. (2004). Epstein-Barr Virus Nuclear Antigen Leader Protein Induces Expression of Thymus- and Activation-Regulated Chemokine in B Cells. J. Virol. 78: 3984-3993 [Abstract] [Full Text]  
• Yue, W., Davenport, M. G., Shackelford, J., Pagano, J. S. (2004). Mitosis-Specific Hyperphosphorylation of Epstein-Barr Virus Nuclear Antigen 2 Suppresses Its Function. J. Virol. 78: 3542-3552 [Abstract] [Full Text]  
• Thompson, M. P., Kurzrock, R. (2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res. 10: 803-821 [Abstract] [Full Text]  
• Peng, C.-W., Xue, Y., Zhao, B., Johannsen, E., Kieff, E., Harada, S. (2004). Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation. Proc. Natl. Acad. Sci. USA 101: 1033-1038 [Abstract] [Full Text]  
• Atkinson, P. G. P., Coope, H. J., Rowe, M., Ley, S. C. (2003). Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-{kappa}B2 p100 to p52. J. Biol. Chem. 278: 51134-51142 [Abstract] [Full Text]  
• Kato, K., Yokoyama, A., Tohya, Y., Akashi, H., Nishiyama, Y., Kawaguchi, Y. (2003). Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J. Gen. Virol. 84: 3381-3392 [Abstract] [Full Text]  
• Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Kieff, E. (2003). Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth. J. Virol. 77: 10437-10447 [Abstract] [Full Text]  
• Johansen, L. M., Deppmann, C. D., Erickson, K. D., Coffin, W. F. III, Thornton, T. M., Humphrey, S. E., Martin, J. M., Taparowsky, E. J. (2003). EBNA2 and Activated Notch Induce Expression of BATF. J. Virol. 77: 6029-6040 [Abstract] [Full Text]  
• Igarashi, M., Kawaguchi, Y., Hirai, K., Mizuno, F. (2003). Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization. J. Gen. Virol. 84: 319-327 [Abstract] [Full Text]  
• Carter, K. L., Cahir-McFarland, E., Kieff, E. (2002). Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression. J. Virol. 76: 10427-10436 [Abstract] [Full Text]  
• Dufva, M., Flodin, J., Nerstedt, A., Ruetschi, U., Rymo, L. (2002). Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation. Nucleic Acids Res 30: 2131-2143 [Abstract] [Full Text]  
• Spender, L. C., Cornish, G. H., Sullivan, A., Farrell, P. J. (2002). Expression of Transcription Factor AML-2 (RUNX3, CBF{alpha}-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype. J. Virol. 76: 4919-4927 [Abstract] [Full Text]  
• Han, I., Xue, Y., Harada, S., Orstavik, S., Skalhegg, B., Kieff, E. (2002). Protein Kinase A Associates with HA95 and Affects Transcriptional Coactivation by Epstein-Barr Virus Nuclear Proteins. Mol. Cell. Biol. 22: 2136-2146 [Abstract] [Full Text]  
• Tanaka, M., Yokoyama, A., Igarashi, M., Matsuda, G., Kato, K., Kanamori, M., Hirai, K., Kawaguchi, Y., Yamanashi, Y. (2002). Conserved Region CR2 of Epstein-Barr Virus Nuclear Antigen Leader Protein Is a Multifunctional Domain That Mediates Self-Association as well as Nuclear Localization and Nuclear Matrix Association. J. Virol. 76: 1025-1032 [Abstract] [Full Text]  
• Lin, J., Johannsen, E., Robertson, E., Kieff, E. (2002). Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2. J. Virol. 76: 232-242 [Abstract] [Full Text]  
• McCann, E. M., Kelly, G. L., Rickinson, A. B., Bell, A. I. (2001). Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function. J. Gen. Virol. 82: 3067-3079 [Abstract] [Full Text]  
• Harris, R. S., Croom-Carter, D. S. G., Rickinson, A. B., Neuberger, M. S. (2001). Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells. J. Virol. 75: 10488-10492 [Abstract] [Full Text]  
• Dufva, M., Olsson, M., Rymo, L. (2001). Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J. Gen. Virol. 82: 1581-1587 [Abstract] [Full Text]  
• Yokoyama, A., Tanaka, M., Matsuda, G., Kato, K., Kanamori, M., Kawasaki, H., Hirano, H., Kitabayashi, I., Ohki, M., Hirai, K., Kawaguchi, Y. (2001). Identification of Major Phosphorylation Sites of Epstein-Barr Virus Nuclear Antigen Leader Protein (EBNA-LP): Ability of EBNA-LP To Induce Latent Membrane Protein 1 Cooperatively with EBNA-2 Is Regulated by Phosphorylation. J. Virol. 75: 5119-5128 [Abstract] [Full Text]  
• Spender, L. C., Cornish, G. H., Rowland, B., Kempkes, B., Farrell, P. J. (2001). Direct and Indirect Regulation of Cytokine and Cell Cycle Proteins by EBNA-2 during Epstein-Barr Virus Infection. J. Virol. 75: 3537-3546 [Abstract] [Full Text]  
• Höfelmayr, H., Strobl, L. J., Marschall, G., Bornkamm, G. W., Zimber-Strobl, U. (2001). Activated Notch1 Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMP1-Expressing Immortalized B Cells. J. Virol. 75: 2033-2040 [Abstract] [Full Text]  
• Han, I., Harada, S., Weaver, D., Xue, Y., Lane, W., Orstavik, S., Skalhegg, B., Kieff, E. (2001). EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95. J. Virol. 75: 2475-2481 [Abstract] [Full Text]  
• Harada, S., Yalamanchili, R., Kieff, E. (2001). Epstein-Barr Virus Nuclear Protein 2 Has at Least Two N-Terminal Domains That Mediate Self-Association. J. Virol. 75: 2482-2487 [Abstract] [Full Text]  
• Peng, R., Tan, J., Ling, P. D. (2000). Conserved Regions in the Epstein-Barr Virus Leader Protein Define Distinct Domains Required for Nuclear Localization and Transcriptional Cooperation with EBNA2. J. Virol. 74: 9953-9963 [Abstract] [Full Text]  
• Kawaguchi, Y., Nakajima, K., Igarashi, M., Morita, T., Tanaka, M., Suzuki, M., Yokoyama, A., Matsuda, G., Kato, K., Kanamori, M., Hirai, K. (2000). Interaction of Epstein-Barr Virus Nuclear Antigen Leader Protein (EBNA-LP) with HS1-Associated Protein X-1: Implication of Cytoplasmic Function of EBNA-LP. J. Virol. 74: 10104-10111 [Abstract] [Full Text]  
• Nicholas, J (2000). Evolutionary aspects of oncogenic herpesviruses. Mol. Pathol. 53: 222-237 [Abstract] [Full Text]  
• Young, L S, Dawson, C W, Eliopoulos, A G (2000). The expression and function of Epstein-Barr virus encoded latent genes. Mol. Pathol. 53: 238-247 [Abstract] [Full Text]  
• Delecluse, H-J, Hammerschmidt, W (2000). The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy. Mol. Pathol. 53: 270-279 [Abstract] [Full Text]  
• Webster-Cyriaque, J., Middeldorp, J., Raab-Traub, N. (2000). Hairy Leukoplakia: an Unusual Combination of Transforming and Permissive Epstein-Barr Virus Infections. J. Virol. 74: 7610-7618 [Abstract] [Full Text]  
• Zhao, B., Sample, C. E. (2000). Epstein-Barr Virus Nuclear Antigen 3C Activates the Latent Membrane Protein 1 Promoter in the Presence of Epstein-Barr Virus Nuclear Antigen 2 through Sequences Encompassing an Spi-1/Spi-B Binding Site. J. Virol. 74: 5151-5160 [Abstract] [Full Text]  
• Kirby, H., Rickinson, A., Bell, A. (2000). The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors. J. Gen. Virol. 81: 1057-1066 [Abstract] [Full Text]  
• Peng, R., Gordadze, A. V., Fuentes Pananá, E. M., Wang, F., Zong, J., Hayward, G. S., Tan, J., Ling, P. D. (2000). Sequence and Functional Analysis of EBNA-LP and EBNA2 Proteins from Nonhuman Primate Lymphocryptoviruses. J. Virol. 74: 379-389 [Abstract] [Full Text]  
• Sjöblom-Hallén, A., Yang, W., Jansson, A., Rymo, L. (1999). Silencing of the Epstein-Barr Virus Latent Membrane Protein 1 Gene by the Max-Mad1-mSin3A Modulator of Chromatin Structure. J. Virol. 73: 2983-2993 [Abstract] [Full Text]  
• Harada, S., Yalamanchili, R., Kieff, E. (1998). Residues 231 to 280 of the Epstein-Barr Virus Nuclear Protein 2 Are Not Essential for Primary B-Lymphocyte Growth Transformation. J. Virol. 72: 9948-9954 [Abstract] [Full Text]  
• Cludts, I., Farrell, P. J. (1998). Multiple Functions within the Epstein-Barr Virus EBNA-3A Protein. J. Virol. 72: 1862-1869 [Abstract] [Full Text]  
• Cahir-McFarland, E. D., Davidson, D. M., Schauer, S. L., Duong, J., Kieff, E. (2000). NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 97: 6055-6060 [Abstract] [Full Text]